Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1989-3-21
pubmed:abstractText
The effect of various well-characterized heparin preparations on the inactivation of human Factor XIa by human antithrombin III was studied. The heparin preparations used were unfractionated heparin and four heparin fractions obtained after anion-exchange chromatography. Inactivation of Factor XIa was monitored with S2366 as chromogenic substrate and followed pseudo-first-order reaction kinetics under all reaction conditions tested. Enhancement of the rate of inhibition of Factor XIa in the presence of unfractionated heparin correlated to the binding of antithrombin III to heparin. From the kinetic data a binding constant of 0.1 microM was inferred. The maximum rate enhancement, achieved at saturating heparin concentrations, was 30-fold. The rate enhancement achieved in the presence of each of the heparin fractions could also be correlated to the binding of antithrombin III to the heparin. The binding constant inferred from the kinetic data varied from 0.10 to 0.28 microM and the number of binding sites for antithrombin III varied from 0.06 to 0.74 site per heparin molecule. The maximum rate enhancements, achieved at saturating heparin concentrations, were strongly dependent on the type of heparin used and varied from 7-fold for fraction A to 41-fold for fraction D. Therefore, although the stimulation of Factor XIa inactivation by antithrombin III could be quantitatively correlated to the binding of antithrombin III to heparin, the heparin-catalysed inhibition of Factor XIa is dependent not only upon the degree of binding of antithrombin III to heparin but also upon the type of heparin to which antithrombin III is bound.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-1012017, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-271951, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-3486013, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-3487352, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-3499176, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-3636155, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-429327, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-486424, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-53066, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-588558, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-6604052, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-6604055, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-6626744, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-6643505, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-6914196, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-7076850, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-7085630, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-7112506, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-893417, http://linkedlifedata.com/resource/pubmed/commentcorrection/3265623-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
256
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
815-20
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
pubmed:affiliation
Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.
pubmed:publicationType
Journal Article